FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings

FDA is kicking off phase two of its 21st Century GMP initiative using new authorities and funding under the FDA Safety & Innovation Act. To encourage investment in quality manufacturing systems, the agency is highlighting the cost savings seen by early adopters of quality systems..

More from Archive

More from Pink Sheet